{"id":198172,"date":"2024-10-19T12:36:55","date_gmt":"2024-10-19T12:36:55","guid":{"rendered":"https:\/\/pdfstandards.shop\/product\/uncategorized\/aami-14937-2009-ra-2013\/"},"modified":"2024-10-25T05:10:06","modified_gmt":"2024-10-25T05:10:06","slug":"aami-14937-2009-ra-2013","status":"publish","type":"product","link":"https:\/\/pdfstandards.shop\/product\/publishers\/aami\/aami-14937-2009-ra-2013\/","title":{"rendered":"AAMI 14937 2009 RA 2013"},"content":{"rendered":"
Specifies general requirements for the characterization of a sterilizing agent and for the development, validation and routine monitoring and control of a sterilization process for medical devices. Applies to sterilization processes in which microorganisms are inactivated by physical and\/or chemical means. Intended to be applied by process developers, manufacturers of sterilization equipment, manufacturers of products to be sterilized and organizations responsible for sterilizing medical devices.<\/p>\n
PDF Pages<\/th>\n | PDF Title<\/th>\n<\/tr>\n | ||||||
---|---|---|---|---|---|---|---|
1<\/td>\n | ANSI\/AAMI\/ISO 14937:2009\/(R)2013, Sterilization of health care products – General requirements for characterization of a sterilizing agent and the development, validation and routine control of a sterilization process for medical devices <\/td>\n<\/tr>\n | ||||||
2<\/td>\n | Objectives and uses of AAMI standards and recommended practices <\/td>\n<\/tr>\n | ||||||
3<\/td>\n | Title page <\/td>\n<\/tr>\n | ||||||
4<\/td>\n | AAMI Standard Copyright information <\/td>\n<\/tr>\n | ||||||
5<\/td>\n | Contents <\/td>\n<\/tr>\n | ||||||
7<\/td>\n | Glossary of equivalent standards <\/td>\n<\/tr>\n | ||||||
9<\/td>\n | Committee Representation <\/td>\n<\/tr>\n | ||||||
11<\/td>\n | Background of AAMI adoption of ANSI\/AAMI\/ISO 14937 <\/td>\n<\/tr>\n | ||||||
12<\/td>\n | Foreword <\/td>\n<\/tr>\n | ||||||
13<\/td>\n | Introduction <\/td>\n<\/tr>\n | ||||||
15<\/td>\n | 1 Scope 1.1 Inclusions 1.2 Exclusions <\/td>\n<\/tr>\n | ||||||
16<\/td>\n | 2 Normative references 3 Terms and definitions <\/td>\n<\/tr>\n | ||||||
22<\/td>\n | 4 Quality management system elements 4.1 Documentation 4.2 Management responsibility 4.3 Product realization 4.4 Measurement, analysis and improvement\u00a0\u2014 Control of non-conforming product 5 Sterilizing agent characterization 5.1 General <\/td>\n<\/tr>\n | ||||||
23<\/td>\n | 5.2 Sterilizing agent 5.3 Microbicidal effectiveness 5.4 Effects on materials 5.5 Safety and the environment <\/td>\n<\/tr>\n | ||||||
24<\/td>\n | 6 Process and equipment characterization 6.1 General 6.2 Process characterization 6.3 Equipment characterization <\/td>\n<\/tr>\n | ||||||
25<\/td>\n | 7 Product definition 8 Process definition <\/td>\n<\/tr>\n | ||||||
26<\/td>\n | 9 Validation 9.1 General <\/td>\n<\/tr>\n | ||||||
27<\/td>\n | 9.2 Installation qualification 9.2.1 Equipment 9.2.2 Installation 9.3 Operational qualification <\/td>\n<\/tr>\n | ||||||
28<\/td>\n | 9.4 Performance qualification <\/td>\n<\/tr>\n | ||||||
29<\/td>\n | 9.5 Review and approval of validation 10 Routine monitoring and control 11 Product release from sterilization <\/td>\n<\/tr>\n | ||||||
30<\/td>\n | 12 Maintaining process effectiveness 12.1 General 12.2 Recalibration 12.3 Maintenance of equipment 12.4 Requalification 12.5 Assessment of change <\/td>\n<\/tr>\n | ||||||
31<\/td>\n | Annex A Factors to be considered in selection of microorganisms for demonstrating microbicidal effectiveness A.1 General A.2 Identification of reference microorganism A.3 Selection of microorganisms <\/td>\n<\/tr>\n | ||||||
33<\/td>\n | Annex B Approach 1 \u2014 Process definition based on inactivation of the microbial population in its natural state B.1 General B.2 Product selection B.3 Procedure B.4 Maintaining process effectiveness <\/td>\n<\/tr>\n | ||||||
34<\/td>\n | Annex C Approach 2 \u2014 Process definition based on inactivation of reference microorganisms and knowledge of bioburden C.1 General C.2 Procedure <\/td>\n<\/tr>\n | ||||||
35<\/td>\n | Annex D Approach 3 \u2014 Conservative process definition based on inactivation of reference microorganisms D.1 General D.2 Procedure <\/td>\n<\/tr>\n | ||||||
37<\/td>\n | Annex E Guidance on application of this International Standard E.1 Scope E.2 Normative references E.3 Terms and definitions E.4 Quality management system elements E.4.1 Documentation E.4.2 Management responsibility <\/td>\n<\/tr>\n | ||||||
41<\/td>\n | E.4.3 Product realization E.4.4 Measurement, analysis and improvement \u2014 Control of non-conforming product E.5 Sterilizing agent characterization E.5.1 General E.5.2 Sterilizing agent E.5.3 Microbicidal effectiveness <\/td>\n<\/tr>\n | ||||||
44<\/td>\n | E.5.4 Effects on materials E.5.5 Safety and the environment E.6 Process and equipment characterization E.7 Product definition <\/td>\n<\/tr>\n | ||||||
45<\/td>\n | E.8 Process definition <\/td>\n<\/tr>\n | ||||||
47<\/td>\n | E.9 Validation E.9.1 General E.9.2 Installation qualification (IQ) E.9.3 Operational qualification (OQ) E.9.4 Performance qualification (PQ) <\/td>\n<\/tr>\n | ||||||
48<\/td>\n | E.9.5 Review and approval of validation E.10 Routine monitoring and control <\/td>\n<\/tr>\n | ||||||
49<\/td>\n | E.11 Product release from sterilization E.12 Maintaining process effectiveness E.12.1 General <\/td>\n<\/tr>\n | ||||||
50<\/td>\n | E.12.2 Recalibration E.12.3 Maintenance of equipment E.12.4 Requalification E.12.5 Assessment of change <\/td>\n<\/tr>\n | ||||||
52<\/td>\n | Bibliography <\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":" ANSI\/AAMI\/ISO 14937:2009\/(R) 2013 – Sterilization of health care products-General requirements for characterization of a sterilizing agent and the development, validation and routine control of a sterilization process for medical devices<\/b><\/p>\n |